← Eichor
Condition: Schizophreniform Disorders Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Schizophreniform Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MicroRNAs as Biomarkers in First Episode Schizophrenia
NA · 1 location(s) · Northwell Health · NCT07703670
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605
iTBS to Enhance Social Cognition in People With Psychosis
NA · 1 location(s) · Northwell Health · NCT06118268
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NA · 1 location(s) · University of California, Los Angeles · NCT05890183
Cognitive Strategies in Early Psychosis 2
Phase 3 · 1 location(s) · University of Minnesota · NCT07263022
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NA · 8 location(s) · Stephanie Mehl · NCT07645443
Bazedoxifene -Treatment for Women With Schizophrenia
Phase 4 · 1 location(s) · The Alfred · NCT04113993
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · 13 location(s) · Dr. Inge Winter · NCT05958875
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.